Actively Recruiting
Same-Day Colectomy: is it Safe for Patients?
Led by University of Arizona · Updated on 2025-09-16
150
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective cohort study of outcomes of patients undergoing outpatient colorectal surgery at a single institution to study outpatient colectomy as a viable treatment option for a select group of patients requiring colon and rectal surgery.
CONDITIONS
Official Title
Same-Day Colectomy: is it Safe for Patients?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 18-70
- Scheduled for robotic-assisted right colectomy, sigmoidectomy, or low anterior resection
- Able to perform more than 4 metabolic equivalents (METS) without shortness of breath
- Have a designated adult caregiver to assist at home after surgery until visiting the clinic
- Have access to a cell phone or computer and running water
- Completed preoperative and postoperative education successfully
- Well controlled hypertension with systolic blood pressure under 140 managed by fewer than two medications with good compliance
- Well controlled diabetes managed only with oral medications and blood glucose below 180 on daily checks
- Antiplatelet agents such as aspirin or clopidogrel stopped 7 days before surgery and restarted on day 1 after surgery
You will not qualify if you...
- Neurocognitive deficits preventing adequate preoperative education
- Congestive heart failure with ejection fraction below 45%
- Symptomatic aortic stenosis causing heart failure, fainting, shortness of breath or chest pain
- Pulmonary fibrosis or pulmonary hypertension
- Chronic obstructive pulmonary disease or home oxygen use over 2 liters
- Any stage of chronic kidney disease
- No caregiver at home or functionally bed-bound
- Ultralow pelvic resection planned
- Need for ostomy creation during surgery
- Surgery lasting longer than 5 hours indicating complexity
- Conversion to open surgery during the procedure
- Use of certain antiplatelet agents within one year of coronary or carotid stent placement, TAVR, or LAAO
- Use of therapeutic anticoagulation medications such as warfarin, Eliquis, Xarelto, or Enoxaparin
- Current tobacco use
- Inability to complete preoperative education or discomfort with home care or lack of caregiver for 7 days after surgery
- Any previous surgery preventing safe robotic abdominal surgery entry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Banner University Medical Center Phoenix
Phoenix, Arizona, United States, 85006
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here